Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanocarrier based approaches for targeting breast cancer stem cells
Sai Kiran S. S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni, et al.
Artificial Cells Nanomedicine and Biotechnology (2017) Vol. 46, Iss. 5, pp. 885-898
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
Vikas Jain, Hitesh Kumar, Haritha V. Anod, et al.
Journal of Controlled Release (2020) Vol. 326, pp. 628-647
Closed Access | Times Cited: 216
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance
Taniya Saha, Kiven Erique Lukong
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 77
Targeting triple negative breast cancer stem cells using nanocarriers
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Signaling pathways governing breast cancer stem cells behavior
Kai Song, Maryam Farzaneh
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 92
Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting
Atmaram Pawar, Srishti Singh, S. Rajalakshmi, et al.
Artificial Cells Nanomedicine and Biotechnology (2018) Vol. 46, Iss. sup1, pp. 347-361
Open Access | Times Cited: 86
Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies
Qi-Yao Wei, Yan‐Ming Xu, Andy T. Y. Lau
Cancers (2020) Vol. 12, Iss. 10, pp. 2783-2783
Open Access | Times Cited: 79
Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance
Refaat A. Eid, Muhammad Alaa Eldeen, Eslam M. Shedid, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1786-1786
Open Access | Times Cited: 37
Nanoscale strides: exploring innovative therapies for breast cancer treatment
Sruthi Laakshmi Mugundhan, M. Mothilal
RSC Advances (2024) Vol. 14, Iss. 20, pp. 14017-14040
Open Access | Times Cited: 12
Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects
Adil Allahverdiyev, Etkin Parlar, Sahar Dinparvar, et al.
Artificial Cells Nanomedicine and Biotechnology (2018) Vol. 46, Iss. sup3, pp. 755-762
Open Access | Times Cited: 49
Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells
Sai Kiran S. S. Pindiprolu, Pavan Kumar Chintamaneni, Praveen Thaggikuppe Krishnamurthy, et al.
Drug Development and Industrial Pharmacy (2018) Vol. 45, Iss. 2, pp. 304-313
Closed Access | Times Cited: 47
Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer
Mohammad Azam Ansari, Muthu Thiruvengadam, Zeba Farooqui, et al.
Seminars in Cancer Biology (2019) Vol. 69, pp. 109-128
Closed Access | Times Cited: 46
Nanocarrier-mediated modulation of cGAS-STING signaling pathway to disrupt tumor microenvironment
Sai Kiran S. S. Pindiprolu, Madhu Tanya Singh, Magham Sai Varshini, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses
Mostafa Yazdan, Seyed Morteza Naghib, M.R. Moepubi
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 12, pp. 896-915
Closed Access | Times Cited: 4
Phenyl Boronic Acid-Modified Lipid Nanocarriers of Niclosamide for Targeting Triple-Negative Breast Cancer
Sai Kiran S. S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Venkata Rao Ghanta, et al.
Nanomedicine (2020) Vol. 15, Iss. 16, pp. 1551-1565
Closed Access | Times Cited: 32
Engineered upconversion nanocarriers for synergistic breast cancer imaging and therapy: Current state of art
Pavan Kumar Chintamaneni, Nagasen Dasari, Katta Chanti Babu, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 652-672
Closed Access | Times Cited: 18
Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells
Madhu Tanya Singh, Praveen Thaggikuppe Krishnamurthy, Magham Sai Varshini
Journal of drug targeting (2024) Vol. 32, Iss. 3, pp. 258-269
Closed Access | Times Cited: 3
Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer
Poonam Banthia, Lokesh Gambhir, Asha Sharma, et al.
3 Biotech (2022) Vol. 12, Iss. 3
Open Access | Times Cited: 14
Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
Li Lv, Yonghui Shi, Junyan Wu, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 1487-1508
Open Access | Times Cited: 19
Navigating the therapeutic landscape for breast cancer: targeting breast cancer stem cells
S. Chatti Dey, Yirivinti Hayagreeva Dinakar, R. Soundarya, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
Pharmacological targets of breast cancer stem cells: a review
Sai Kiran S. S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni
Naunyn-Schmiedeberg s Archives of Pharmacology (2018) Vol. 391, Iss. 5, pp. 463-479
Closed Access | Times Cited: 21
Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer
Mamta Kumari, Praveen Thaggikuppe Krishnamurthy, Piyong Sola
Current Cancer Drug Targets (2020) Vol. 20, Iss. 8, pp. 559-572
Closed Access | Times Cited: 20
CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma
Sai Harshini Pindiprolu, Sai Kiran S. S. Pindiprolu
Medical Hypotheses (2019) Vol. 129, pp. 109241-109241
Closed Access | Times Cited: 18
Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer: in vitro studies
Mantosh Kumar Singh, Sai Kiran S. S. Pindiprolu, Bharat Kumar Reddy Sanapalli, et al.
RSC Advances (2019) Vol. 9, Iss. 43, pp. 24987-24994
Open Access | Times Cited: 16
Nanotherapeutics for the Treatment of Cancer and Arthritis
Pal Patel, Nikita Meghani, Krupa Kansara, et al.
Current Drug Metabolism (2018) Vol. 20, Iss. 6, pp. 430-445
Closed Access | Times Cited: 16
Facile synthesis of multi‐walled carbon nanotube via folic acid grafted nanoparticle for precise delivery of doxorubicin
Pravin S. Uttekar, Sameer Lakade, Vijay K. Beldar, et al.
IET Nanobiotechnology (2019) Vol. 13, Iss. 7, pp. 688-696
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top